Researchers Submit Patent Application, 'Estrogen Receptor Beta Ligands For The Prevention And Treatment Of Multiple Sclerosis (Ms) And Other Demyelinating, Inflammatory And Neurodegenerative Diseases', for Approval (USPTO 20210230121)

MLA

“Researchers Submit Patent Application, ’Estrogen Receptor Beta Ligands For The Prevention And Treatment Of Multiple Sclerosis (Ms) And Other Demyelinating, Inflammatory And Neurodegenerative Diseases’, for Approval (USPTO 20210230121).” Obesity, Fitness & Wellness Week, Aug. 2021, p. 1353. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.672113700&authtype=sso&custid=ns315887.

APA

Researchers Submit Patent Application, ’Estrogen Receptor Beta Ligands For The Prevention And Treatment Of Multiple Sclerosis (Ms) And Other Demyelinating, Inflammatory And Neurodegenerative Diseases’, for Approval (USPTO 20210230121). (2021, August 21). Obesity, Fitness & Wellness Week, 1353.

Chicago

Obesity, Fitness & Wellness Week. 2021. “Researchers Submit Patent Application, ’Estrogen Receptor Beta Ligands For The Prevention And Treatment Of Multiple Sclerosis (Ms) And Other Demyelinating, Inflammatory And Neurodegenerative Diseases’, for Approval (USPTO 20210230121),” August 21. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.672113700&authtype=sso&custid=ns315887.